Recent research shows targeted removal of dysfunctional B cells in aged mice improves immune function and healthspan, suggesting new therapeutic avenues for combating age-related decline. A new study ...
Recent studies show targeted epigenetic reprogramming with Yamanaka factors rejuvenates neurons, reversing cognitive decline in aged mice and reducing Alzheimer’s markers, with AI enhancing safe...
New research on position effect variegation in Drosophila reveals epigenetic aging markers, linking heterochromatin stability to longevity and informing anti-aging therapies. Recent studies show PEV i...
Life Biosciences receives FDA clearance for the first human trial of cellular reprogramming targeting glaucoma and NAION, signaling regulatory openness to longevity therapies and potential vision rest...
A Nature Aging study shows mitochondrial stress enhances senolytic drugs like navitoclax, improving senescent cell removal by 40% with metabolic interventions. New research reveals mitochondrial stres...
A Harvard study in BMJ Medicine finds that engaging in multiple types of physical activity reduces all-cause mortality by up to 19%, with recent data reinforcing this trend. Recent research highlights...
Recent studies show small molecules efficiently mimic Yamanaka factors to reverse epigenetic aging, with clinical trials on the horizon, offering a safer alternative to gene therapies. Advancements in...
Analysis of metabolites like taurine and NAD+ in aging research, highlighting animal studies, human trials, and ethical considerations for longevity strategies. Emerging research on metabolites reveal...
Recent studies show exercise lowers biological aging by reducing inflammatory markers like β2-microglobulin, with 37.67% of anti-aging effects mediated through this pathway. New research reveals how ...
Recent studies highlight histone succinylation as a key epigenetic regulator of aging, with succinic acid supplementation showing promise for enhancing healthspan in mouse models and human trials. Eme...